NDC properties for NDC 9 0065-0647
NDC item 00065064705
| NDC 9 | 0065-0647 |
|---|---|
| NDC 10 | 0065-0647-05 |
| NDC Item | 00065064705 |
| packaging | 5 mL in 1 BOTTLE, PLASTIC (0065-0647-05) |
| FDA SPL set id | 692142 |
| Labeler | Alcon Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 1988-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050592 |
NDC item 00065064710
| NDC 9 | 0065-0647 |
|---|---|
| NDC 10 | 0065-0647-10 |
| NDC Item | 00065064710 |
| packaging | 10 mL in 1 BOTTLE, PLASTIC (0065-0647-10) |
| FDA SPL set id | 692142 |
| Labeler | Alcon Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 1988-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050592 |
NDC item 00065064725
| NDC 9 | 0065-0647 |
|---|---|
| NDC 10 | 0065-0647-25 |
| NDC Item | 00065064725 |
| packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0065-0647-25) |
| FDA SPL set id | 692142 |
| Labeler | Alcon Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 1988-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050592 |
NDC item 00078095325
| NDC 9 | 0078-0953 |
|---|---|
| NDC 10 | 0078-0953-25 |
| NDC Item | 00078095325 |
| packaging | 5 mL in 1 BOTTLE (0078-0953-25) |
| FDA SPL set id | 706700 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1988-09-15 |
| Marketing status | ACTIVE |
| NDA | NDA050592 |
NDC item 00078095326
| NDC 9 | 0078-0953 |
|---|---|
| NDC 10 | 0078-0953-26 |
| NDC Item | 00078095326 |
| packaging | 10 mL in 1 BOTTLE (0078-0953-26) |
| FDA SPL set id | 706700 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1988-09-15 |
| Marketing status | ACTIVE |
| NDA | NDA050592 |
NDC item 00078095340
| NDC 9 | 0078-0953 |
|---|---|
| NDC 10 | 0078-0953-40 |
| NDC Item | 00078095340 |
| packaging | 2.5 mL in 1 BOTTLE (0078-0953-40) |
| FDA SPL set id | 706700 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1988-09-15 |
| Marketing status | ACTIVE |
| NDA | NDA050592 |
NDC item 43063000501
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 43063000501 |
NDC item 52959009200
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 52959009200 |
NDC item 52959009201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 52959009201 |
NDC item 52959009203
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 52959009203 |
NDC item 66267093705
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 66267093705 |